Rafael Sánchez‐Sánchez

1.1k total citations
29 papers, 746 citations indexed

About

Rafael Sánchez‐Sánchez is a scholar working on Molecular Biology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Rafael Sánchez‐Sánchez has authored 29 papers receiving a total of 746 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Epidemiology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Rafael Sánchez‐Sánchez's work include RNA Research and Splicing (9 papers), RNA modifications and cancer (6 papers) and Prostate Cancer Treatment and Research (6 papers). Rafael Sánchez‐Sánchez is often cited by papers focused on RNA Research and Splicing (9 papers), RNA modifications and cancer (6 papers) and Prostate Cancer Treatment and Research (6 papers). Rafael Sánchez‐Sánchez collaborates with scholars based in Spain, United States and Australia. Rafael Sánchez‐Sánchez's co-authors include Raúl M. Luque, Manuel D. Gahete, Justo P. Castaño, Juan M. Jiménez‐Vacas, Enrique Gómez‐Gómez, Antonio C. Fuentes-Fayos, Sergio Pedraza‐Arévalo, Rosa Ortega‐Salas, Emilia Alors‐Pérez and Fernando L‐López and has published in prestigious journals such as PLoS ONE, Brain and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Rafael Sánchez‐Sánchez

29 papers receiving 740 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rafael Sánchez‐Sánchez Spain 16 395 177 165 146 109 29 746
Jianning Zhang China 15 470 1.2× 255 1.4× 148 0.9× 243 1.7× 44 0.4× 28 839
Xianrui Yuan China 18 522 1.3× 128 0.7× 175 1.1× 249 1.7× 62 0.6× 61 949
Hung‐Pei Tsai Taiwan 14 287 0.7× 96 0.5× 87 0.5× 142 1.0× 66 0.6× 68 732
Dariusz J. Jaskólski Poland 17 286 0.7× 269 1.5× 175 1.1× 201 1.4× 105 1.0× 96 962
Michał Rynkowski Poland 13 232 0.6× 387 2.2× 141 0.9× 90 0.6× 58 0.5× 34 809
Shoichi Nagai Japan 15 228 0.6× 151 0.9× 140 0.8× 111 0.8× 52 0.5× 45 642
Alejandro Ibáñez‐Costa Spain 18 312 0.8× 106 0.6× 299 1.8× 109 0.7× 77 0.7× 49 902
Zhong Xu China 18 417 1.1× 127 0.7× 176 1.1× 303 2.1× 67 0.6× 48 882
Lianhua Zhao China 11 156 0.4× 152 0.9× 110 0.7× 44 0.3× 59 0.5× 23 444
Justin Massengale United States 7 296 0.7× 167 0.9× 220 1.3× 252 1.7× 64 0.6× 10 800

Countries citing papers authored by Rafael Sánchez‐Sánchez

Since Specialization
Citations

This map shows the geographic impact of Rafael Sánchez‐Sánchez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafael Sánchez‐Sánchez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafael Sánchez‐Sánchez more than expected).

Fields of papers citing papers by Rafael Sánchez‐Sánchez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rafael Sánchez‐Sánchez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafael Sánchez‐Sánchez. The network helps show where Rafael Sánchez‐Sánchez may publish in the future.

Co-authorship network of co-authors of Rafael Sánchez‐Sánchez

This figure shows the co-authorship network connecting the top 25 collaborators of Rafael Sánchez‐Sánchez. A scholar is included among the top collaborators of Rafael Sánchez‐Sánchez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rafael Sánchez‐Sánchez. Rafael Sánchez‐Sánchez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sánchez‐Sánchez, Rafael, Enrique Gómez‐Gómez, Antonio J. Martínez‐Fuentes, et al.. (2024). Dysregulation of RNA-Exosome machinery is directly linked to major cancer hallmarks in prostate cancer: Oncogenic role of PABPN1. Cancer Letters. 584. 216604–216604. 2 indexed citations
2.
Fuentes-Fayos, Antonio C., Rafael Sánchez‐Sánchez, Rosa Ortega‐Salas, et al.. (2023). Metformin and simvastatin exert additive antitumour effects in glioblastoma via senescence-state: clinical and translational evidence. EBioMedicine. 90. 104484–104484. 33 indexed citations
3.
Pedraza‐Arévalo, Sergio, Emilia Alors‐Pérez, Aura D. Herrera‐Martínez, et al.. (2022). Spliceosomic dysregulation unveils NOVA1 as a candidate actionable therapeutic target in pancreatic neuroendocrine tumors. Translational research. 251. 63–73. 12 indexed citations
4.
Fuentes-Fayos, Antonio C., Juan M. Jiménez‐Vacas, Rafael Sánchez‐Sánchez, et al.. (2022). SF3B1 inhibition disrupts malignancy and prolongs survival in glioblastoma patients through BCL2L1 splicing and mTOR/ß-catenin pathways imbalances. Journal of Experimental & Clinical Cancer Research. 41(1). 39–39. 26 indexed citations
5.
Jiménez‐Vacas, Juan M., Enrique Gómez‐Gómez, Antonio C. Fuentes-Fayos, et al.. (2022). Tumor suppressor role of RBM22 in prostate cancer acting as a dual-factor regulating alternative splicing and transcription of key oncogenic genes. Translational research. 253. 68–79. 4 indexed citations
6.
Fuentes-Fayos, Antonio C., Mari C. Vázquez‐Borrego, Juan M. Jiménez‐Vacas, et al.. (2020). Splicing machinery dysregulation drives glioblastoma development/aggressiveness: oncogenic role of SRSF3. Brain. 143(11). 3273–3293. 56 indexed citations
7.
Jiménez‐Vacas, Juan M., Vicente Herrero‐Aguayo, Enrique Gómez‐Gómez, et al.. (2020). Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancer. EBioMedicine. 51. 102547–102547. 72 indexed citations
8.
Coelho, Maria Caroline Alves, Luiz Eduardo Wildemberg, Mari C. Vázquez‐Borrego, et al.. (2019). Clinical significance of filamin A in patients with acromegaly and its association with somatostatin and dopamine receptor profiles. Scientific Reports. 9(1). 1122–1122. 25 indexed citations
9.
Gómez‐Gómez, Enrique, Juan M. Jiménez‐Vacas, Sergio Pedraza‐Arévalo, et al.. (2019). Oncogenic Role of Secreted Engrailed Homeobox 2 (EN2) in Prostate Cancer. Journal of Clinical Medicine. 8(9). 1400–1400. 12 indexed citations
10.
Río-Moreno, Mercedes del, Emilia Alors‐Pérez, Gustavo Ferrín, et al.. (2019). Dysregulation of the Splicing Machinery Is Associated to the Development of Nonalcoholic Fatty Liver Disease. The Journal of Clinical Endocrinology & Metabolism. 104(8). 3389–3402. 58 indexed citations
11.
Jiménez‐Vacas, Juan M., Vicente Herrero‐Aguayo, Enrique Gómez‐Gómez, et al.. (2019). Spliceosome component SF3B1 as novel prognostic biomarker and therapeutic target for prostate cancer. Translational research. 212. 89–103. 53 indexed citations
12.
Herrera‐Martínez, Aura D., Manuel D. Gahete, Rafael Sánchez‐Sánchez, et al.. (2018). Ghrelin-O-Acyltransferase (GOAT) Enzyme as a Novel Potential Biomarker in Gastroenteropancreatic Neuroendocrine Tumors. Clinical and Translational Gastroenterology. 9(10). e196–e196. 9 indexed citations
13.
Herrera‐Martínez, Aura D., Manuel D. Gahete, Sergio Pedraza‐Arévalo, et al.. (2017). Clinical and functional implication of the components of somatostatin system in gastroenteropancreatic neuroendocrine tumors. Endocrine. 59(2). 426–437. 28 indexed citations
14.
Oreja‐Guevara, Celia, Ulises Gómez‐Pinedo, Rafael Sánchez‐Sánchez, et al.. (2017). Inhibition of neurogenesis in a case of Marburg variant multiple sclerosis. Multiple Sclerosis and Related Disorders. 18. 71–76. 8 indexed citations
15.
Hormaechea‐Agulla, Daniel, Manuel D. Gahete, Juan M. Jiménez‐Vacas, et al.. (2017). The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressiveness. Molecular Cancer. 16(1). 146–146. 38 indexed citations
16.
Herrera‐Martínez, Aura D., Manuel D. Gahete, Rafael Sánchez‐Sánchez, et al.. (2017). The components of somatostatin and ghrelin systems are altered in neuroendocrine lung carcinoids and associated to clinical-histological features. Lung Cancer. 109. 128–136. 18 indexed citations
17.
Luque, Raúl M., Fernando L‐López, Rafael Sánchez‐Sánchez, et al.. (2016). Lack of cortistatin or somatostatin differentially influences DMBA-induced mammary gland tumorigenesis in mice in an obesity-dependent mode. Breast Cancer Research. 18(1). 29–29. 8 indexed citations
18.
López‐Sánchez, Laura M., Juan R. Muñoz‐Castañeda, Manuel Rodríguez‐Perálvarez, et al.. (2015). GCDCA down-regulates gene expression by increasing Sp1 binding to the NOS-3 promoter in an oxidative stress dependent manner. Biochemical Pharmacology. 96(1). 39–51. 17 indexed citations
19.
Sánchez‐Sánchez, Rafael, et al.. (2014). Rosette-forming glioneuronal tumour (RGNT) of the fourth ventricle: a highly aggressive case. Brain Tumor Pathology. 32(2). 124–130. 33 indexed citations
20.
Gahete, Manuel D., José Córdoba‐Chacón, Daniel D. Lantvit, et al.. (2014). Elevated GH/IGF-I promotes mammary tumors in high-fat, but not low-fat, fed mice. Carcinogenesis. 35(11). 2467–2473. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jianning Zhang Breakdown of academic impact, for papers by Xianrui Yuan Breakdown of academic impact, for papers by Hung‐Pei Tsai Breakdown of academic impact, for papers by Dariusz J. Jaskólski Breakdown of academic impact, for papers by Michał Rynkowski Breakdown of academic impact, for papers by Shoichi Nagai Breakdown of academic impact, for papers by Alejandro Ibáñez‐Costa Breakdown of academic impact, for papers by Zhong Xu Breakdown of academic impact, for papers by Lianhua Zhao Breakdown of academic impact, for papers by Justin Massengale
Rankless by CCL
2026